Biovica establishes DiviTum(R) TKa Commercialization Partnership in Italy

Biovica International Biovica, active in cancer monitoring, announces that the company has signed a commercial partnership agreement with the Italian company, IT Health Fusion, for the commercialization of the DiviTum® TKa assay in Italy.

Scroll to Top